David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$365M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$307M |
| 3 |
Adobe
ADBE
|
+$250M |
| 4 |
NVIDIA
NVDA
|
+$242M |
| 5 |
Salesforce
CRM
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$520M |
| 2 |
ExxonMobil
XOM
|
+$372M |
| 3 |
Bank of America
BAC
|
+$271M |
| 4 |
Netflix
NFLX
|
+$172M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.36% |
| 2 | Technology | 13.15% |
| 3 | Financials | 9.51% |
| 4 | Healthcare | 7.52% |
| 5 | Consumer Discretionary | 6.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HUYA
2701
Huya Inc
HUYA
$493M
| $2.37M | ﹤0.01% |
1,067,157
-467,037
| -30% | -$1.51M |
|
|
ESPR
2702
DELISTED
Esperion Therapeutics
ESPR
| $2.35M | ﹤0.01% |
351,039
-352,439
| -50% | -$2.42M |
|
2703
CALL
Jabil
JBL
$32.5B
| $2.35M | ﹤0.01% |
+40,700
| New | +$2.37M |
|
2704
Atlantic Union Bankshares
AUB
$5.86B
| $2.35M | ﹤0.01% |
77,191
-24,212
| -24% | -$816K |
|
2705
CALL
Teck Resources
TECK
$34.9B
| $2.35M | ﹤0.01% |
+77,200
| New | +$2.38M |
|
2706
CALL
Voya Financial
VOYA
$9.2B
| $2.34M | ﹤0.01% |
+38,700
| New | +$2.37M |
|
2707
CALL
Prologis
PLD
$135B
| $2.34M | ﹤0.01% |
23,000
| – | – |
|
2708
Morningstar
MORN
$8.21B
| $2.32M | ﹤0.01% |
10,911
+3,818
| +54% | +$908K |
|
|
GLHA
2709
DELISTED
Glass Houses Acquisition Corp. Class A common stock
GLHA
| $2.32M | ﹤0.01% |
235,508
| – | – |
|
2710
Unisys
UIS
$198M
| $2.32M | ﹤0.01% |
306,709
+12,008
| +4% | +$128K |
|
2711
PUT
Vertex Pharmaceuticals
VRTX
$138B
| $2.32M | ﹤0.01% |
8,000
-10,000
| -56% | -$2.88M |
|
2712
SelectQuote
SLQT
$95.3M
| $2.31M | ﹤0.01% |
3,171,360
-584,917
| -16% | -$972K |
|
2713
Plains GP Holdings
PAGP
$5.56B
| $2.31M | ﹤0.01% |
212,143
+45,694
| +27% | +$524K |
|
2714
Packaging Corp of America
PKG
$21.7B
| $2.31M | ﹤0.01% |
20,530
-71,738
| -78% | -$9.71M |
|
2715
Hancock Whitney
HWC
$6.03B
| $2.3M | ﹤0.01% |
50,241
+8,411
| +20% | +$405K |
|
2716
CALL
General Mills
GIS
$22.1B
| $2.3M | ﹤0.01% |
30,000
+23,700
| +376% | +$1.81M |
|
2717
Kilroy Realty
KRC
$4.27B
| $2.3M | ﹤0.01% |
+54,565
| New | +$2.75M |
|
2718
Markel Group
MKL
$22.5B
| $2.29M | ﹤0.01% |
2,117
+1,787
| +542% | +$2.18M |
|
|
MITA
2719
DELISTED
Coliseum Acquisition Corp. Class A Ordinary Share
MITA
| $2.29M | ﹤0.01% |
233,729
+39,630
| +20% | +$387K |
|
2720
UiPath
PATH
$9.52B
| $2.29M | ﹤0.01% |
+181,951
| New | +$3.19M |
|
2721
CALL
Insulet
PODD
$10.1B
| $2.29M | ﹤0.01% |
10,000
| – | – |
|
2722
PUT
DaVita
DVA
$11.5B
| $2.29M | ﹤0.01% |
27,700
-20,400
| -42% | -$1.79M |
|
2723
CALL
Brunswick
BC
$5.06B
| $2.28M | ﹤0.01% |
+34,900
| New | +$2.62M |
|
2724
Brinker International
EAT
$9.88B
| $2.28M | ﹤0.01% |
91,330
+63,730
| +231% | +$1.72M |
|
2725
CALL
monday.com
MNDY
$4.24B
| $2.28M | ﹤0.01% |
20,100
| – | – |
|
Similar funds
David Shaw's Q3 2022 Portfolio in Review
As of Q3 2022, David Shaw held 5,820 positions worth $83.7B, down 1.8% from $85.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
David Shaw withdrew a net $7.97B in Q3 2022, closing 678 positions and reducing 1,597 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $171M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 41% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
Against the trend, David Shaw opened a new position in Prologis worth $66.1M.
- David Shaw's largest Q3 2022 buy was Prologis: 650,725 shares worth $66.1M.
- David Shaw added most to Visa in Q3 2022, an estimated $365M increase.
- David Shaw's biggest Q3 2022 reduction was PayPal, cutting an estimated $520M.
- David Shaw fully exited iShares MSCI Emerging Markets ETF in Q3 2022, selling an estimated $171M.
- David Shaw's ten largest holdings make up 8.7% of its $83.7B portfolio in Q3 2022.
- David Shaw opened 545 new positions and closed 678 in Q3 2022.
- David Shaw's portfolio value fell 1.8% quarter-over-quarter to $83.7B.
Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.